91 results about "Immuno suppression" patented technology

The invention relates to the technical field of mesenchymal stem cells for cell therapy, in particular to a method for strengthening an immune-suppression function of the mesenchymal stem cells. Separated mesenchymal stem cells are sub-cultured and then cultured in a culture medium containing IFN-gamma, IL-1beta and progesterone. After subjected to co-cultivation and activation of the IFN-gamma, theIL-1beta and the progesterone, the suppression ratio of the MSC cells to lymphocyte proliferation is improved by 2-7 times, the expression of immune-suppression protein in the MSC cells is improved by 2-12 times, the capacity of cell secretion anti-inflammatory cytokines is improved by 5-20 times, and the capacity of secretion proinflammatory cytokines is reduced by 10%-30%, and the immune-suppression activity of the MSC cells is increased greatly.

Apparatus and methods are disclosed for treating allergic rhinitis (seasonal and perennial hay fever), by application of flash lamp radiation. The nasal cavity can be illuminated in a safe and effective manner, with non-coherent light from a flash-lamp or other suitable source. This illumination can be accomplished in any suitable manner, including by use of a handheld device. Such handheld embodiments may contain a power source (battery or AC), control circuitry, light source (flash-lamp or diode laser), lens (focusing or non-focusing), light filter, and / or fiber-optic for delivering light to the nasal cavity. Embodiments include using any suitable light energy, such as visible light in the red wavelengths with a power output of 1 to 10 Joules per cm2. The device can be pre-programmed to deliver a specified amount of light in a specified amount of time using multiple pulses (in the case of a flash lamp) or a continuous wave (in the case of a diode laser). In many useful embodiments, a rigid fiber-optic extends from the lens / light filter a length of 10 to 20 mm, although it can be any convenient and useful size and shape. Contact sensors can be arrayed on the device for various purposes, such as to restrict illumination to times when the fiber optic is inserted into the nasal cavity. This and / or other safety features can prevent the high-intensity light from being fired into open space, a person's eyes, and / or otherwise causing a potential vision or other hazard. Preferably, the device can be easily and comfortably inserted into a nostril. The fiber-optic can be angled (either in its own shape or by the user manipulating it to a convenient angle / position) so as to allow the user to easily grip the device and insert the fiber-optic without having to use a mirror or other aid. Light from the device can be emitted at a specified light frequency that causes a desired immunosuppressive response in the cellular system.

An extract of prunella spike for treating rheumatoid arthritis and improving immune suppression contains phenolic acid (60-70%) and rosemaric acid (14-21%). Its preparing process is also disclosed.

The invention discloses a preparation method and applications of a class of heterocyclic compounds with immunomodulatory effect, specifically a compound with a structure represented by a formula I, wherein various groups are defined in the specification. The invention further provides applications of the compounds in the fields of immunity regulation and PD-1 / PD-L1 inhibition.

The present invention discloses a method of treating an individual having irritable bowel syndrome or a related disorder, comprising the step of administering to said individual a pharmacologically effective dose of a luminally active anti-inflammatory or immunosuppressive compound with minimal or no systemic side effects. Further provided is a method of inhibiting the onset of symptoms of irritable bowel syndrome or a related disorder in an individual in need of such treatment, comprising the step of administering to the individual a prophylactically effective dose of a luminally active anti-inflammatory or immunosuppressive compound with minimal or no systemic side effects.

Use of dhS1P and / or PhotoImmunoNanoTherapy as a therapeutic agent is described. Administration of therapeutically effective amounts of dhS1P decrease the number of Myeloid Derived Suppressor Cells and immune suppression in cancer patients. Administration of therapeutically effective amounts of dhS1P can be used as an adjuvant to conventional cancer therapies including immunotherapies. Therapeutic results can be achieved by directly administering dhS1P and / or by indirectly increasing the amount of dhS1P at the tumor site. The therapy permits the patient's immune system to recognize and eliminate cancer cells reducing tumor size and extending patient survival.